Vanguard Fiduciary Trust
APYX icon

Vanguard Fiduciary Trust’s Apyx Medical APYX Stock Holding History

Vanguard Fiduciary Trust’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.01M Buy
224,021
+21,340
+11% +$84.6K ﹤0.01% 3017
2026
Q1 		$748K Buy
+202,681
New +$757K ﹤0.01% 3046

Other funds holding APYX

RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3B AUM 119.43% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIM
Essex Investment Management Boston, Massachusetts $763M AUM 108.51% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
HKAM
Horizon Kinetics Asset Management New York $8.82B AUM 23.05% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Fiduciary Trust's APYX Position: Q2 2026 in Review

Vanguard Fiduciary Trust increased its Apyx Medical (APYX) stake by 11% in Q2 2026, buying an estimated $84.6K and bringing the position to 224,021 shares worth $1.01M. The position accounts for ﹤0.01% of the portfolio, ranked #3017.

Vanguard Fiduciary Trust first reported a position in APYX in Q1 2026 and has held it in 2 quarters since. 68 funds tracked by Wall St. Rank hold APYX as of Q2 2026.

  • Vanguard Fiduciary Trust held 224,021 shares of Apyx Medical worth $1.01M as of Q2 2026.
  • Vanguard Fiduciary Trust bought 21,340 Apyx Medical shares in Q2 2026, an estimated $84.6K.
  • Apyx Medical made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #3017 holding.
  • Vanguard Fiduciary Trust first reported a position in Apyx Medical in Q1 2026 and has held it in 2 quarters since.
  • 68 funds tracked by Wall St. Rank held Apyx Medical as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.